93
Views
110
CrossRef citations to date
0
Altmetric
Article

Overexpression of PKD1 Causes Polycystic Kidney Disease

, , , , &
Pages 1538-1548 | Received 07 Oct 2005, Accepted 04 Dec 2005, Published online: 27 Mar 2023

REFERENCES

  • Blouin, M. J., H. Beauchemin, A. Wright, M. E. De Paepe, M. Sorette, A.-M. Bleau, B. Nakamoto, C.-N. Ou, G. Stamatoyannopoulos, and M. Trudel. 2000. Genetic correction of sickle cell disease: insights using transgenic mouse models. Nat. Med. 6:177–182.
  • Boulter, C., S. Mulroy, S. Webb, S. Fleming, K. Brindle, and R. Sandford. 2001. Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene. Proc. Natl. Acad. Sci. USA 98:12174–12179.
  • Brasier, J. L., and E. P. Henske. 1997. Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis. J. Clin. Investig. 99:194–199.
  • Burn, T. C., T. D. Connors, W. R. Dackowski, L. R. Petry, T. J. Van Raay, J. M. Millholland, M. Venet, G. Miller, R. M. Hakim, G. M. Landes, K. W. Klinger, F. Qian, L. F. Onuchic, T. Watnick, G. G. Germino, and N. A. Doggett. 1995. Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat. Hum. Mol. Genet. 4:575–582.
  • Chada, K., J. Magram, K. Raphael, G. Radice, E. Lacy, and F. Costantini. 1985. Specific expression of a foreign β-globin gene in erythroid cells of transgenic mice. Nature 314:377–380.
  • Chauvet, V., F. Qian, N. Boute, Y. Cai, B. Phakdeekitacharoen, L. F. Onuchic, T. Attie-Bitach, L. Guicharnaud, O. Devuyst, G. G. Germino, and M.-C. Gubler. 2002. Expression of PKD1 and PKD2 transcripts and proteins in human embryo and during normal kidney development. Am. J. Pathol. 160:973–983.
  • Chauvet, V., X. Tian, H. Husson, D. H. Grimm, T. Wang, T. Hiesberger, P. Igarashi, A. M. Bennett, O. Ibraghimov-Beskrovnaya, S. Somlo, and M. J. Caplan. 2004. Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus. J. Clin. Investig. 114:1433–1443.
  • Cheadle, J. P., M. P. Reeve, J. R. Sampson, and D. J. Kwiatkowski. 2000. Molecular genetic advances in tuberous sclerosis. Hum. Genet. 107:97–114.
  • Consortium, E. P. K. D. 1993. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305–1315.
  • Consortium, E. P. K. D. 1994. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77:881–894.
  • Consortium, I. P. K. D. 1995. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 81:289–298.
  • Couillard, M., R. Guillaume, N. Tanji, V. D'Agati, and M. Trudel. 2002. c-myc-Induced apoptosis in polycystic kidney disease is independent of FasL/Fas interaction. Cancer Res. 62:2210–2214.
  • De Paepe, M. E., and M. Trudel. 1994. The transgenic SAD mouse: a model of human sickle cell glomerulopathy. Kidney Int. 46:1337–1345.
  • Geng, L., Y. Segal, B. Peissel, N. Deng, Y. Pei, F. Carone, H. G. Rennke, A. M. Glücksmann-Kuis, M. C. Schneider, M. Ericsson, S. T. Reeders, and J. Zhou. 1996. Identification and localization of polycystin, the PKD1 gene product. J. Clin. Investig. 98:2674–2682.
  • Gong, S., X. W. Yang, C. Li, and N. Heintz. 2002. Highly efficient modification of bacterial artificial chromosomes (BACs) using novel shuttle vectors containing the R6Kγ origin of replication. Genome Res. 12:1992–1998.
  • Guillaume, R., V. D'Agati, M. Daoust, and M. Trudel. 1999. Murine Pkd1 is a developmentally regulated gene from morula to adulthood: role in tissue condensation and patterning. Dev. Dyn. 214:337–348.
  • Guillaume, R., and M. Trudel. 2000. Distinct and common developmental expression patterns of the murine PKD2 and PKD1 genes. Mech. Dev. 93:179–183.
  • Ibraghimov-Beskrovnaya, O., W. R. Dackowski, L. Foggensteiner, N. Coleman, S. Thiru, L. R. Petry, T. C. Burn, T. D. Connors, T. Van Raay, J. Bradley, F. Qian, L. F. Onuchic, T. J. Watnick, K. Piontek, R. M. Hakim, G. M. Landes, G. G. Germino, R. Sandford, and K. W. Klinger. 1997. Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein. Proc. Natl. Acad. Sci. USA 94:6397–6402.
  • Kim, K., I. Drummond, O. Ibraghimov-Beskrovnaya, K. Klinger, and M. A. Arnaout. 2000. Polycystin 1 is required for the structural integrity of blood vessels. Proc. Natl. Acad. Sci. USA 97:1731–1736.
  • Kobayashi, T., O. Minowa, J. Kuno, H. Mitani, O. Hino, and T. Noda. 1999. Renal Carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice. Cancer Res. 59:1206–1211.
  • Koptides, M., R. Constantinides, G. Kyriakides, M. Hadjigavriel, P. C. Patsalis, A. Pierides, and C. C. Deltas. 1998. Loss of heterozygosity in polycystic kidney disease with a missense mutation in the repeated region of PKD1. Hum. Genet. 103:709–717.
  • Lanoix, J., V. D'Agati, M. Szabolcs, and M. Trudel. 1996. Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD). Oncogene 13:1153–1160.
  • Lantinga-van Leeuwen, I. S., J. G. Dauwerse, H. J. Baelde, W. N. Leonhard, A. van de Wal, C. J. Ward, S. Verbeek, M. C. Deruiter, M. H. Breuning, E. de Heer, and D. J. M. Peters. 2004. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. Hum. Mol. Genet. 13:3069–3077.
  • Lu, W., B. Peissel, H. Babakhanlou, A. Pavlova, L. Geng, X. Fan, C. Larson, G. Brent, and J. Zhou. 1997. Perinatal lethality with kidney and pancreas defects in mice with a targetted PKD1 mutation. Nat. Genet. 17:179–181.
  • Lu, W., X. Shen, A. Pavlova, M. Lakkis, C. J. Ward, L. Pritchard, P. C. Harris, D. R. Genest, A. R. Perez-Atayde, and J. Zhou. 2001. Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects. Hum. Mol. Genet. 10:2385–2396.
  • Muto, S., A. Aiba, Y. Saito, K. Nakao, K. Nakamura, K. Tomita, T. Kitamura, M. Kurabayashi, R. Nagai, E. Higashihara, P. C. Harris, M. Katsuki, and S. Horie. 2002. Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant. Hum. Mol. Genet. 11:1731–1742.
  • Olsson, P. G., C. Lohning, S. Horsley, L. Kearney, P. C. Harris, and A.-M. Frischauf. 1996. The mouse homologue of the polycystic kidney disease gene (Pkd1) is a single-copy gene. Genomics 34:233–235.
  • Onda, H., A. Lueck, P. W. Marks, H. B. Warren, and D. J. Kwiatkowski. 1999. Tsc2+/− mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J. Clin. Investig. 104:687–698.
  • Ong, A. C. M., C. J. Ward, R. J. Butler, S. Biddolph, C. Bowker, R. Torra, Y. Pei, and P. C. Harris. 1999. Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue. Am. J. Pathol. 154:1721–1729.
  • Peters, D. J. M., A. Van De Wal, L. Spruit, J. J. Saris, M. H. Breuning, J. A. Bruijn, and E. de Heer. 1999. Cellular localization and tissue distribution of polycystin-1. J. Pathol. 188:439–446.
  • Pritchard, L., J. A. Sloane-Stanley, J. A. Sharpe, R. Aspinwall, W. Lu, V. Buckle, L. Strmecki, D. Walker, C. J. Ward, C. E. Alpers, J. Zhou, W. G. Wood, and P. C. Harris. 2000. A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype. Hum. Mol. Genet. 9:2617–2627.
  • Qian, F., T. J. Watnick, L. F. Onuchic, and G. G. Germino. 1996. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 87:979–987.
  • Rossetti, S., D. Chauveau, D. Walker, A. Saggar-Malik, C. G. Winearls, V. E. Torres, and P. C. Harris. 2002. A complete mutation screen of the ADPKD genes by DHPLC. Kidney Int. 61:1588–1599.
  • Rossetti, S., L. Strmecki, V. Gamble, S. Burton, V. Sneddon, B. Peral, S. Roy, A. Bakkaloglu, R. Komel, C. G. Winearls, and P. C. Harris. 2001. Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications. Am. J. Hum. Genet. 68:46–63.
  • Trudel, M., L. Barisoni, J. Lanoix, and V. D'Agati. 1998. Polycystic kidney disease in SBM transgenic mice: role of c-myc in disease induction and progression. Am. J. Pathol. 152:219–229.
  • Trudel, M., V. D'Agati, and F. Costantini. 1991. c-myc as an inducer of polycystic kidney disease in transgenic mice. Kidney Int. 39:665–671.
  • Trudel, M., and R. Guillaume. 2000. Molecular biology of autosomal dominant polycystic kidney disease. Pediatr. Pathol. Mol. Med. 18:483–499.
  • Trudel, M., J. Lanoix, L. Barisoni, M.-J. Blouin, M. Desforges, C. L'Italien, and V. D'Agati. 1997. C-MYC-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent. J. Exp. Med. 186:1873–1884.
  • Ward, C. J., H. Turley, A. C. M. Ong, M. Comley, S. Biddolph, R. Chetty, P. J. Ratcliffe, K. Gatter, and P. C. Harris. 1996. Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult and polycystic kidney. Proc. Natl. Acad. Sci. USA 93:1524–1528.
  • Wu, G., X. Tian, S. Nishimura, G. S. Markowitz, V. D'Agati, J. H. Park, L. Yao, L. Li, L. Geng, H. Zhao, W. Edelmann, and S. Somlo. 2002. Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystin kidney disease. Hum. Mol. Genet. 11:1845–1854.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.